Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

NewAmsterdam Pharma (NAMS) SEC Filings & 10K Form

NewAmsterdam Pharma logo
$24.05 +0.10 (+0.42%)
Closing price 04:00 PM Eastern
Extended Trading
$24.04 -0.02 (-0.06%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent NewAmsterdam Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
08/27/2025
3:57 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2025
4:08 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025
4:03 PM		Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2025
4:04 PM		Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
4:28 PM		Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SCHEDULE 13D/A
08/18/2025
7:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2025
11:56 AM		Capital World Investors (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SCHEDULE 13G/A
08/12/2025
3:30 PM		Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SCHEDULE 13D/A
08/06/2025
6:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2025
6:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
7:25 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
3:12 PM		NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2025
3:25 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
6:41 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:42 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:50 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
11:31 AM		NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
8:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
6:28 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
3:35 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:40 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
10:44 AM		Capital World Investors (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SCHEDULE 13G
05/08/2025
3:28 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form ARS
05/08/2025
7:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
6:36 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
4:41 PM		LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:34 PM		Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
4:36 PM		Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:41 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:06 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
4:36 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:18 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:20 PM		Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:24 PM		LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:29 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
5:19 PM		Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
5:00 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
3:27 PM		Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:29 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
11:15 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
03/10/2025
3:52 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
03/06/2025
4:32 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:10 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:54 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:06 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/26/2025
7:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
7:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2025
4:24 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:42 PM		NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
01/31/2025
4:00 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:25 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:16 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:09 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
3:52 PM		NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Somaiya Mayur Ian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
3:26 PM		NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:27 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:58 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:03 PM		Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:08 PM		McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:09 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
4:57 PM		LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM		Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM		Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:08 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:10 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:12 PM		JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:29 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/06/2025
4:57 PM		Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:48 PM		Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:51 PM		JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:53 PM		NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:54 PM		Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:56 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:15 PM		Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:15 PM		Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:15 PM		Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:25 PM		Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:15 PM		Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:35 PM		BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/17/2024
4:05 PM		Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:00 PM		Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/17/2024
9:28 AM		Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/16/2024
3:15 PM		Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:28 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:33 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
12/12/2024
3:15 PM		Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:57 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-3MEF
12/10/2024
3:48 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
12/10/2024
6:24 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This is my Christian duty (Ad)

“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel

Watch Jim Rickards reveal the Old Testament Wealth Code
11/20/2024
6:07 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:29 PM		Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
11/14/2024
4:46 PM		NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/06/2024
7:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:00 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
7:02 AM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 20-F/A
10/18/2024
3:51 PM		NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
4:01 PM		Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:23 PM		Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NAMS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel